Preimplantation Genetic Diagnosis (PGD) Market is expected to grow at a CAGR of 10% during the forecast period. Global Preimplantation Genetic Diagnosis (PGD) Market is expected to reach US$ 1277.76 Mn. by 2029. The Global Preimplantation Genetic Diagnosis (PGD) Market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The Global Preimplantation Genetic Diagnosis (PGD) Market report also provides trends by market segments, technology, and investment with a competitive landscape.Preimplantation Genetic Diagnosis (PGD) Market Overview:
Preimplantation Genetic Diagnosis (PGD) is performed to seek more desirable embryos for implantation. Preimplantation Genetic Diagnosis is carried out under two steps that include extraction of one or two cells from an In-vitro Fertilization (IVF) produced embryo and application of Preimplantation Genetic Diagnostic (PGD) test.To know about the Research Methodology :- Request Free Sample Report
Preimplantation Genetic Diagnosis (PGD) Market Dynamics:
The preimplantation genetic diagnosis (PGD) market is expected to witness notable growth in the coming years owing to the rising prevalence of genetic, hereditary, and chromosomal diseases. Moreover, preimplantation genetic diagnosis (PGD) has a high chance of perceiving healthy embryos and avoiding genetic defects in the unborn fetus. This test and diagnosis are highly expensive and middle-class families cannot afford it hence this factor can hamper the growth of the market in the forecast period. Moreover, as the technologies are growing with the market demand and latest innovation this is further boosting the market growth of preimplantation genetic diagnosis (PGD) in a positive direction. This factor is also creating major opportunities in the market for the market players to invest in technologies due to high demand. Moreover, awareness in consumers regarding developing healthy embryos by preimplantation of genetic diagnosis is further fueling the market growth.Preimplantation Genetic Diagnosis (PGD) Market Segment Analysis:
Chromosomal abnormalities are trending in the test type segment of preimplantation genetic diagnosis (PGD) Market The chromosomal abnormalities segment is gaining wider attraction due to the adoption of preimplantation genetic diagnosis (PGD. The segment is anticipated to increase in market share due to growing genetic defects, hereditary and chromosomal abnormalities in unborn as well as elderly individuals. However, stringent government regulations related to the application of preimplantation genetic diagnosis can hamper the growth of the market shortly as consumers are misusing the technologies. Additionally, sex determination is strictly banned by the government in countries like India to save girl children and to improve gender ratio and the Pre-Conception and Prenatal Diagnostic Techniques Act (prohibition of sex selection) was amended in 1994 to prohibit sex determination and this factor hampered the growth market. Further, Single-gene disorders, aneuploidy, and X-linked disease are some of the other segments in preimplantation Genetic Diagnosis (PGD)Preimplantation Genetic Diagnosis (PGD) Market Regional Insights:
Preimplantation Genetic Diagnosis (PGD) Market Regional Insights is segmented into North America, Asia Pacific, Latin America, Europe, Middle East, and Africa. Asia Pacific is dominating the preimplantation genetic diagnosis (PGD) market. The dominating countries of Asia Pacific are China, India, Japan boosting the market growth due to technological advancement and modernization in the region. Moreover, Asia Pacific is growing due to developing countries in the region and huge industrialization in the region. The adoption of the In-vitro fertilization technique is boosting the application of the preimplantation genetic diagnosis market. This technique is used in identifying the development of the fetus and chromosomal abnormalities of genetic defects that can hamper the growth of the fetus in the mother's womb. Europe is second dominating in the preimplantation genetic diagnosis (PGD) market. As the region has a high infrastructure and developed health care system with high technologies. Moreover, the region has marked a high number of late pregnancies due to the application of In-vitro Fertilization in the region. The objective of the report is to present a comprehensive analysis of the Global Preimplantation Genetic Diagnosis (PGD) Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Preimplantation Genetic Diagnosis (PGD) Market dynamics, structure by analyzing the market segments and project the Global Preimplantation Genetic Diagnosis (PGD) Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Preimplantation Genetic Diagnosis (PGD) Market make the report investor’s guide.Preimplantation Genetic Diagnosis (PGD) Market Scope: Inquire before buying
Preimplantation Genetic Diagnosis (PGD) Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 655.69 Mn. Forecast Period 2023 to 2029 CAGR: 10 % Market Size in 2029: US $ 1277.76 Mn. Segments Covered: by Test Type • Chromosomal abnormalities • Gender selection • X-linked diseases • Aneuploidy • Single gene disorders • Others Preimplantation Genetic Diagnosis (PGD) Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)Preimplantation Genetic Diagnosis (PGD) Market Key Players :
• Reprogenetics • LLC • Genea Limited, • Illumina, Inc. • Laboratory Corporation of America Holdings • Natera, Inc. • PerkinElmer, Inc. • Quest Diagnostics Incorporated • Genesis Genetics Ltd. • Reproductive Genetics Innovations LLC Frequently Asked Questions: 1. Which region has the largest share in Global Preimplantation Genetic Diagnosis (PGD) Market? Ans: Asia Pacific region held the highest share in 2022. 2. What is the growth rate of Global Preimplantation Genetic Diagnosis (PGD) Market? Ans: The Global Preimplantation Genetic Diagnosis (PGD) Market is growing at a CAGR of 10 % during forecasting period 2023-2029. 3. What is scope of the Global Preimplantation Genetic Diagnosis (PGD) Market report? Ans: Global Preimplantation Genetic Diagnosis (PGD) Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Preimplantation Genetic Diagnosis (PGD) Market? Ans: The important key players in the Global Preimplantation Genetic Diagnosis (PGD) Market are – Reprogenetics, LLC, Genea Limited,, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., PerkinElmer, Inc., Quest Diagnostics Incorporated, Genesis Genetics Ltd., Reproductive Genetics Innovations LLC 5. What is the study period of this Market? Ans: The Global Preimplantation Genetic Diagnosis (PGD) Market is studied from 2022 to 2029.
1.Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Preimplantation Genetic Diagnosis (PGD) Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Pneumonia Diagnostics & Technologies Market 3.4. Geographical Snapshot of the Pneumonia Diagnostics & Technologies Market, By Manufacturer share 4. Global Preimplantation Genetic Diagnosis (PGD) Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Grades 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Preimplantation Genetic Diagnosis (PGD) Market 5. Supply Side and Demand Side Indicators 6. Global Preimplantation Genetic Diagnosis (PGD) Market Analysis and Forecast, 2022-2029 6.1. Global Preimplantation Genetic Diagnosis (PGD) Market Size & Y-o-Y Growth Analysis. 7. Global Preimplantation Genetic Diagnosis (PGD) Market Analysis and Forecasts, 2022-2029 7.1. Other Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 7.1.1. Chromosomal abnormalities 7.1.2. Gender selection 7.1.3. X-linked diseases 7.1.4. Aneuploidy 7.1.5. Single gene disorders 7.1.6. Others 8. Global Preimplantation Genetic Diagnosis (PGD) Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 9.1.1. Chromosomal abnormalities 9.1.2. Gender selection 9.1.3. X-linked diseases 9.1.4. Aneuploidy 9.1.5. Single gene disorders 9.1.6. Others 10. North America Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 12. Canada Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 13. Mexico Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 14. Europe Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 15. Europe Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 17. France Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 18. Germany Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 19. Italy Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 20. Spain Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 21. Sweden Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 22. CIS Countries Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 23. Rest of Europe Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 24. Asia Pacific Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 25. Asia Pacific Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 27. India Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 28. Japan Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 29. South Korea Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 30. Australia Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 31. ASEAN Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 32. Rest of Asia Pacific Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 33. Middle East Africa Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 34. Middle East Africa Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 36. GCC Countries Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 37. Egypt Textile Reinforced Concrete e Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 38. Nigeria Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 39. Rest of ME&A Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 40. South America Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 41. South America Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 43. Argentina Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Types, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 44. Rest of South America Pneumonia Diagnostics & Technologies Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Test Type, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Preimplantation Genetic Diagnosis (PGD) Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. PerkinElmer 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Reprogenetics 45.3.3. LLC 45.3.4. Genea Limited, 45.3.5. Illumina, Inc. 45.3.6. Laboratory Corporation of America Holdings 45.3.7. Natera, Inc. 45.3.8. PerkinElmer, Inc. 45.3.9. Quest Diagnostics Incorporated 45.3.10. Genesis Genetics Ltd. 45.3.11. Reproductive Genetics Innovations LLC. 46. Primary Key Insights